Affy's Schiffman Steps Down; Quackenbush Joins Helicos' SAB; Strategic Diagnostics' CFO Resigns; Abbott Alumnus to Run IntegraGen's US Expansion; and Others | GenomeWeb
The headline for this article has been updated from a previous version, which incorrectly identified Robert Gottlieb as an ABI alumnus instead of an Abbott alumnus.
 
NEW YORK (GenomeWeb News) — Gregory Schiffman has left his various senior executive positions at Affymetrix to take on the role of senior vice president and chief financial officer at Dendreon, a Seattle-based drug developer.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.